11，Regimbeau JM,Olivier F,Bai YS,et al. Is surgery for largehepatocellular carcinoma Justified. J Hepatol,1999,31(2):1062～1068.
22，Neaud V,Faouzi S,Guirouilh J,et al. Human hepatic myofibroblasts increase invasivenessof hepatocellular carcinoma cells:eidence for a role of hepatocyte growth factor.Hepatology,1997,26(6):1458～1463.
33，Picardo A,Howard M,Karpoff,et al. Partial hepatectomy accelerates local tumorgrowth:potential roles of local cytokine activation. Surgery,1998,124(1):57～64.
44，Santoni RE,Jenson MR,Thorgeirsson SS,et al. Disruption of the pRb/E2F pathway andinhibition of apoptosis are major oncogenic events in liver constitutively expresing c-mycand transforming growth factor alpha. Cancer Res,1998,58(1):123～130.
55，Tsai JF,Jeng JE,Chuang LY,et al. Elevated urinary transforming growth facyor-beta 1 asa tumor marker and predictor of poor survival in cirrhotic hepatocellular carcinoma.Cancer,1997,76(2):244～254.
66，Pardoux C,Paturel CA,Chehimi J,et al. Functional interaction between TGF-β and IL-12in human primary allogeneic cytoxicity and proliferative response. JImmunol,1997,158(1):136～143.
77，Gressner AM,Lahme B,Mannherz HG,et al. TGF-beta-mediated hepatocellular apoptosis byrat and human hepatoma cells and primary rat hepatocytes. J Hepatol,1997,26(5):1079～1083.
88，Choi KS,Lim IK,Brady JN,et al. ICE-like protease(caspase)is involved in transforminggrowth factor beta l-mediated apoptosis in FaO rat hepatoma cell line.Hepatology,1998,27(2):415～422.
99，Sohda T,Yun K,Iwata K,et al. Increased expression of insulin-like growth factor Ⅱ inhepatocellular carcionma is primarily regulated at the ranscriptional level. LabInvest,1996,75(3):307～309.
1010，Sohda T,Oka Y,Iwata K,et al. Co-location of insulin-like growth factor Ⅱ and theproliferation marker MIBI in hepatocellular carcinoma cells. J Clin Pathol,1997,50(2):135～137.
4Dranoff G. Cytokines in cancer pathogenesis and cancer therapy.Nat Rev Cancer, 2004, 4:11-22.
5Tanigawa K, Sakaida Ⅰ, MasuharaM, et al. Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases. J Gastroenterol, 2000, 35: 112-119.
6NaKanishi K,Fujimoto J,Ueki T,et al. Hepatocyte growth factor promotes migration of human hepatocellular carcinoma via phosphatidylinositol 3 - Kinase. Clin Exp Metastasis, 1999, 17:507-514.
7He J, Li Q, Zaide W, et al. Increased ievei of serum hepatocyte growth factor/scatter factor in liver cancer is associated with tumor metastasis. In Vivo, 1999,13:177- 180.
8Kamiyama T, Une Y,Uchino J, et al. Hepatocyte growth factor enhances the invasion activity of human hepatocellular carcinoma cell lines. Int J Oncol, 1998,12: 655 -659.
9Junbo H,Li Q, Zaide W,et al. Increased level of serum HGF(HSF) in liver cancer is associated with tumor metastasis. In Vivo, 1999,13(2): 177-180.
